Intravitreal Faricimab in Patients With Refractory Macular Edema
NCT07093385
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
43
Enrollment
OTHER
Sponsor class
Conditions
Age-Related Macular Degeneration
Interventions
DRUG:
Faricimab Injection
Sponsor
University of Baghdad